单纯使用试验总结统计数据,可以评估个性化治疗的潜在益处吗?
Nina Galanter1, Marco Carone1, Ronald C Kessler2
1Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA 98195, United States.
American journal of epidemiology
|April 28, 2024
概括
本研究引入了一种方法来确定个性化医疗治疗的潜在益处,仅使用临床试验的总结统计数据. 它帮助研究人员避免在收集不必要的患者数据上浪费资源.
科学领域:
- 生物统计学 生物统计学
- 临床试验方法论 临床试验方法论
- 翻译医学是一种翻译医学.
背景情况:
- 个性化治疗分配可以提高患者的治疗结果,特别是在具有可变比较治疗效果的疾病中.
- 假设仅仅基于临床试验中不同患者反应的治疗效果异质性可能是误导性的.
- 调查共同变量数据以预测差异性治疗反应可能是资源密集的,如果结果的变化主要不是治疗驱动的.
研究的目的:
- 开发一种方法来限制最佳治疗分配的益处,仅使用已发表的临床试验的总结统计数据.
- 为分层共变量设置提供替代边界.
- 通过评估其潜在价值来指导收集额外的共变量数据的决策.
主要方法:
- 开发了一种利用临床试验总结统计数据的方法,以确定个性化治疗分配的好处的上限.
- 结合了试验结果的替代边界,通过额外的共变量进行分层.
- 通过大抑郁症治疗试验的总结统计数据证明了这一方法.
- 实施了rct2otrbounds R包中的方法.
主要成果:
- 拟议的方法为最佳治疗分配提供了上限.
- 小的上限表明,从收集额外的共变量数据中获得的收益最小.
- 这种方法在抑郁症治疗试验数据集上得到了成功的证明.
结论:
- 开发的方法提供了一个有价值的工具,用于评估个性化医疗的潜在收益,使用随时可用的总结统计数据.
- 它通过识别收集广泛的共变量数据不太可能在治疗分配中产生显著改善的情况,从而帮助分配资源.
- 这些发现特别适用于元分析和评估治疗效果异质性的研究人员.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
503
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:20Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
01:24Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
01:12Hazard Ratio
115
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
115
01:12Statistical Software for Data Analysis and Clinical Trials
540
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
540
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345